Critical Care Medicine · 2000 · 32 citations · 20 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyClinical PharmacologyPharmacodynamicsAnemiaMethylene Blue TherapyN-acetylcysteine TherapyMethemoglobin FormationMethylene Blue EfficacyN-acetylcysteine PharmacologyNitric OxideNitric Oxide DonorsRiboflavin Supplementation
OBJECTIVE: To investigate the treatment of nitric oxide (NO)-induced methemoglobinemia by methylene blue (MB), riboflavin, and N-acetylcysteine (NAC) in vitro. DESIGN: Prospective, controlled in vitro study. SETTING: Research laboratory in a university hospital. PARTICIPANTS: Five healthy volunteers. INTERVENTIONS: Generation of 16% to 18% of methemoglobin in red blood cells by NO and subsequent addition of MB, riboflavin, or NAC. Simultaneous NO (32 ppm) and MB or riboflavin exposure of red blood cells. Induction of 14% to 18% of methemoglobin in red blood cells by NO, subsequent addition of MB or riboflavin, and further incubation with NO (80 ppm). MEASUREMENTS AND MAIN RESULTS: After discontinuation of NO, mean half-life for methemoglobin was significantly reduced by MB from 356 mins (controls) to 5 mins (10 microM) in a dose-dependent manner (p < .001). NAC did not alter the half-life for methemoglobin, and a reduction from 356 to 168 mins was seen for 120 microM riboflavin (p < .001). Methemoglobin formation after 3 hrs of NO exposure was 4.3%+/-0.7% in controls and 0.3%+/-0.1% with 10 microM MB (p < .001); 1 microM MB attenuated methemoglobin formation to 1.9%+/-0.1% (p < .01). With riboflavin (120 microM), methemoglobin was 2.2%+/-0.5% vs. 3.2%+/-0.6% in controls (p < .001). In the presence of high methemoglobin concentrations, further methemoglobin formation was inhibited by 1 and 10 microM MB (p < .001) and attenuated by 0.1 microM MB (p < .001) but not by riboflavin. CONCLUSIONS: In vitro, NO-induced methemoglobin formation is significantly decreased by medium (1 microM) and high (10 microM) concentrations of MB and partially by high riboflavin concentrations (120 microM). NAC and low concentrations of riboflavin do not alter methemoglobin formation.
20
Carl A. Gruetter, Darlene Y. Gruetter, Jessica Lyon et al. · Journal of Pharmacology and Experimental Therapeutics · 1981 · 534 citations
Warren M. Zapol, Stephen Rimar, Nancy Gillis et al. · American Journal of Respiratory and Critical Care Medicine · 1994 · 278 citations
Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome
Sueha Demirakca, J Dötsch, Christoph Knothe et al. · Critical Care Medicine · 1996 · 82 citations
Medicine, Child Health, Pediatrics +17